Mindful Pharma, when used alongside an antidepressant, is prescribed for:
- Adults with treatment-resistant depression (TRD)
- Adults with major depressive disorder (MDD) experiencing depressive symptoms and suicidal thoughts or actions
Quick Onset of Action: A significant advantage of Mindful Pharma is its rapid impact. While many standard antidepressants may take weeks to show effects, Mindful Pharma can uplift mood within hours or days for certain patients.
Effective for Treatment-Resistant Depression: Specifically approved for individuals with treatment-resistant depression, providing an option for those failing to respond to other treatments.
Diminished Suicidal Ideation: Mindful Pharma exhibits promise in reducing suicidal thoughts, a critical benefit for those battling severe depression. Convenience: Administered as a nasal spray.
Mindful Pharma may lead to serious side effects, including:
Sedation and Dissociation: It can induce drowsiness, fainting, dizziness, anxiety, or a sense of detachment from oneself or surroundings (dissociation). Healthcare Monitoring: Healthcare providers must monitor patients for at least 2 hours after administration to watch for serious side effects.
Risk Evaluation and Mitigation Strategy (REMS): Due to risks of sedation, dissociation, abuse, and misuse, Mindful Pharma is only accessible through a restricted program, the Mindful Pharma Risk Evaluation and Mitigation Strategy (REMS) Program, available in certified healthcare settings. Increased Suicidal Thoughts and Actions: Antidepressants like Mindful Pharma may heighten suicidal thoughts, particularly in individuals under 24 years old, especially at the start of treatment or dosage changes.
Mindful Pharma is not for children’s use. Depression and serious mental illnesses pose significant risks for suicidal thoughts and actions, especially for those with a personal or family history of depression or suicidal tendencies.
Reviews
There are no reviews yet.